(Q46554978)

23 December 2017

title

Intravitreal triamcinolone acetonide for patients with macular oedema due to central retinal vein occlusion in Taiwan (English)

1 reference

23 December 2017

central retinal vein occlusion

main subject

1 reference

K-C Cheng

1

1 reference

23 December 2017

W-C Wu

series ordinal

2

1 reference

23 December 2017

C-J Lin

series ordinal

3

1 reference

23 December 2017

publication date

6 June 2008

1 reference

23 December 2017

published in

Eye

1 reference

23 December 2017

volume

23

1 reference

23 December 2017

issue

4

1 reference

23 December 2017

page(s)

849-857

1 reference

23 December 2017

https://scigraph.springernature.com/pub.10.1038/eye.2008.136

exact match

0 references

cites work

Laser-induced chorioretinal venous anastomosis for treatment of nonischemic central retinal vein occlusion

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2008.136

Evaluation of the Retinal Toxicity and Pharmacokinetics of Dexamethasone After Intravitreal Injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2008.136

Natural history and clinical management of central retinal vein occlusion. The Central Vein Occlusion Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2008.136

7 January 2021

Laser-induced chorioretinal venous anastomosis for nonischemic central retinal vein occlusion: evaluation of the complications and their risk factors

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2008.136

7 January 2021

Chorioretinal venous anastomoses: effect of different laser methods and energy in human eyes without vein occlusion

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2008.136

7 January 2021

Evaluation of grid pattern photocoagulation for macular edema in central vein occlusion. The Central Vein Occlusion Study Group M report

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2008.136

7 January 2021

Radial optic neurotomy for central retinal vein occlusion: a retrospective pilot study of 11 consecutive cases

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2008.136

7 January 2021

Injection of tissue plasminogen activator into a branch retinal vein in eyes with central retinal vein occlusion

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2008.136

7 January 2021

Intravitreal triamcinolone for uveitic cystoid macular edema: an optical coherence tomography study.

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2008.136

7 January 2021

Intraocular injection of crystalline cortisone as adjunctive treatment of diabetic macular edema

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2008.136

7 January 2021

Intravitreal triamcinolone for refractory diabetic macular edema

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2008.136

7 January 2021

Relation between reduction of foveal thickness and visual acuity in diabetic macular edema treated with intravitreal triamcinolone

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2008.136

7 January 2021

Intravitreal injection of crystalline cortisone as adjunctive treatment of proliferative diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2008.136

7 January 2021

Intravitreal triamcinolone in the treatment of serous retinal detachment in Vogt-Koyanagi-Harada syndrome.

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2008.136

7 January 2021

Intravitreal triamcinolone acetonide for treatment of sympathetic ophthalmia

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2008.136

7 January 2021

Branch retinal vein occlusion treated by intravitreal triamcinolone acetonide

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2008.136

7 January 2021

Intravitreal triamcinolone acetonide for the management of diabetic papillopathy

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2008.136

7 January 2021

Intravitreal triamcinolone acetonide for macular oedema due to central retinal vein occlusion

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2008.136

7 January 2021

Intravitreal triamcinolone acetonide in eyes with cystoid macular edema associated with central retinal vein occlusion

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2008.136

7 January 2021

Intravitreal triamcinolone acetonide treatment of macular edema associated with central retinal vein occlusion

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2008.136

7 January 2021

Intravitreal triamcinolone acetonide for cystoid macular edema in nonischemic central retinal vein occlusion

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2008.136

7 January 2021

Intravitreal triamcinolone for the treatment of macular edema associated with central retinal vein occlusion

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2008.136

7 January 2021

Intravitreal triamcinolone treatment for macular edema associated with central retinal vein occlusion and hemiretinal vein occlusion.

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2008.136

7 January 2021

One-year safety and efficacy of intravitreal triamcinolone acetonide for the management of macular edema secondary to central retinal vein occlusion

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2008.136

7 January 2021

Intravitreal triamcinolone for acute central retinal vein occlusion; a randomized clinical trial

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2008.136

7 January 2021

Macular oedema in central retinal vein occlusion treated with intravitreal triamcinolone

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2008.136

7 January 2021

In vitro effects of dexamethasone on hypoxia-induced hyperpermeability and expression of vascular endothelial growth factor.

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2008.136

7 January 2021

Vascular endothelial growth factor upregulation in human central retinal vein occlusion

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2008.136

7 January 2021

The clearance of intravitreal triamcinolone acetonide

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2008.136

7 January 2021

The lack of toxicity of intravitreally administered triamcinolone acetonide

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2008.136

7 January 2021

Experimental and clinical observations of the intraocular toxicity of commercial corticosteroid preparations

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2008.136

7 January 2021

Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion: a short-term study

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2008.136

7 January 2021

Identifiers

DOI

10.1038/EYE.2008.136

1 reference

23 December 2017

release_ebxy3ny6nbav5bhpwzusudlbpe

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ebxy3ny6nbav5bhpwzusudlbpe

24 November 2022

mapped directly with Wikidata item

1 reference

23 December 2017